Neoplasms Metastasis Recruiting Phase 2 Trials for Pertuzumab (DB06366)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00781612A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent StudiesTreatment